4:
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.
Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X.
BMC Cancer. 2008 Mar 28;8:83.
PMID: 18373849 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
7:
Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.
Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, Ye S.
Cancer Res. 2007 Nov 1;67(21):10214-21.
PMID: 17974962 [PubMed - indexed for MEDLINE]
Related Articles
10:
Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH, Salgado R, Elst H, Van Dam P, Weyler J, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY.
Breast Cancer Res. 2005;7(2):R210-9. Epub 2005 Jan 10.
PMID: 15743502 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
14:
c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.
Quaranta M, Daniele A, Coviello M, Savonarola A, Abbate I, Venneri MT, Paradiso A, Stea B, Zito A, Labriola A, Schittulli F.
Tumori. 2006 Jul-Aug;92(4):311-7.
PMID: 17036522 [PubMed - indexed for MEDLINE]
Related Articles